MapmyGenome launched a new RT-PCR based Tuberculosis diagnostic kit in India, expanding their molecular diagnostics portfolio for infectious diseases. The kit offers high accuracy at low cost, making it suitable for urban and rural diagnostic labs across the country.
This builds on MapmyGenome’s existing CE-certified Spoligo TB™ kit, which is used for speedy detection and typing of large numbers of TB samples and is already deployed in Africa, South America, and Europe.
About MapmyGenome’s Diagnostics Portfolio
MapmyGenome offers molecular diagnostic tests for TB and other infectious diseases that increase accuracy at very low costs. Their personal genomics portfolio includes Genomepatri™, Cardiomap™, and Oncomap™.
MapmyGenome — Better Health Through Technology
From TB diagnostics to personal genomics, MapmyGenome is India’s pioneer in DNA-based health solutions. Genomepatri covers 100+ health conditions, nutrition, fitness, and drug response traits — all from a simple saliva sample.
